Succession of DKFZ Chairman and Scientific Director open
Wolfgang Wick to remain at Heidelberg University Hospital
Heidelberg University Hospital and the German Cancer Research Center have announced that, following a short period of negotiations, the Medical Director of the Department of Neurology at Heidelberg University Hospital, Professor Dr. Wolfgang Wick, will no longer be assuming the position of Chairman and Scientific Member of the Management Board of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).
© dkfz.de
“We regret that Wolfgang Wick will not be taking over the position of Chairman and Scientific Director at the German Cancer Research Center,” said the Members of the DKFZ Management Board, Professor Otmar D. Wiestler (Chairman and Scientific Director) and Professor Josef Puchta (Administrative-Commercial Director).
“Professor Wick will further expand the National Center for Tumor Diseases. For this important role, it is essential that he continues his work in clinically oriented research,” says Professor Dr. Guido Adler, Chief Medical Director and Chairman of the Board of Heidelberg University Hospital. “We are pleased that our neurologist and excellent researcher, still in the early phases of his position in the Neurology Department, will stay at our hospital,” commented Professor Dr. Wolfgang Herzog, Dean of the Medical Faculty at Heidelberg University.
“Through his collaboration with the NCT and as head of a Clinical Cooperation Unit of DKFZ and Heidelberg University Hospital, he will continue to be closely linked with cancer research at the DKFZ,” said Wiestler with an optimistic look into the future.
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.
